Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

Researchers reported that a single-dose therapeutic interfering particle (TIP) lowers SARS-CoV-2 pathogenesis and shedding among hamsters.

Two Years into the COVID-19 Pandemic: Lessons Learned

Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants, Journal of Nanobiotechnology

Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target

Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences

Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment, Microbial Cell Factories

A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model - ScienceDirect

IJMS, Free Full-Text

Frontiers SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement - Kurt R. Stenmark, Maria G. Frid, Evgenia Gerasimovskaya, Hui Zhang, Mary K. McCarthy, Joshua M. Thurman, Thomas E. Morrison, 2021

Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences

What Happens When You Catch More than One Virus?

Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection

Hamster models of COVID-19 pneumonia reviewed: How human can they be? - Achim D. Gruber, Theresa C. Firsching, Jakob Trimpert, Kristina Dietert, 2022